Serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AAR) is one of the most frequent indicators to discriminate fibrosis and cirrhosis. However, the results remained controversial. The aim of this study was to evaluate the predictive effect of AAR on hepatitis B virus (HBV)-related cirrhosis development.

中文翻译：

---

AST 与 ALT 比率作为慢性 HBV 感染患者肝硬化的前瞻性风险预测因子。

血清天冬氨酸转氨酶（AST）与丙氨酸转氨酶（ALT）比率（AAR）是区分纤维化和肝硬化的最常见指标之一。然而，结果仍然存在争议。本研究的目的是评估 AAR 对乙型肝炎病毒 (HBV) 相关肝硬化发展的预测作用。